Does ELOTUZUMAB Cause Progressive multifocal leukoencephalopathy? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Progressive multifocal leukoencephalopathy have been filed in association with ELOTUZUMAB (EMPLICITI). This represents 0.6% of all adverse event reports for ELOTUZUMAB.
22
Reports of Progressive multifocal leukoencephalopathy with ELOTUZUMAB
0.6%
of all ELOTUZUMAB reports
0
Deaths
12
Hospitalizations
How Dangerous Is Progressive multifocal leukoencephalopathy From ELOTUZUMAB?
Of the 22 reports, 12 (54.5%) required hospitalization, and 2 (9.1%) were considered life-threatening.
Is Progressive multifocal leukoencephalopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELOTUZUMAB. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does ELOTUZUMAB Cause?
Plasma cell myeloma (339)
Death (234)
Malignant neoplasm progression (227)
Pneumonia (209)
Pyrexia (183)
Drug ineffective (137)
Neutropenia (133)
Anaemia (119)
Thrombocytopenia (107)
Diarrhoea (105)
What Other Drugs Cause Progressive multifocal leukoencephalopathy?
NATALIZUMAB (1,668)
RITUXIMAB (1,647)
CYCLOPHOSPHAMIDE (782)
PREDNISONE (606)
PREDNISOLONE (439)
TACROLIMUS (438)
METHOTREXATE (428)
DOXORUBICIN (421)
MYCOPHENOLATE MOFETIL (414)
VINCRISTINE (376)
Which ELOTUZUMAB Alternatives Have Lower Progressive multifocal leukoencephalopathy Risk?
ELOTUZUMAB vs ELOXATIN
ELOTUZUMAB vs ELRANATAMAB
ELOTUZUMAB vs ELRANATAMAB-BCMM
ELOTUZUMAB vs ELTROMBOPAG
ELOTUZUMAB vs ELTROMBOPAG OLAMINE